SCHEMBL1418005

SCHEMBL1418005

CCOC(=O)CC1CCN(C/C=C/C(=O)Nc2cc3c(Nc4cccc(Br)c4)c(C#N)cnc3cc2OC)CC1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.77
▸ ERBB2 P04626 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1418008 1.00 EGFR (0.77) EGFRERBB2
SCHEMBL6382006 0.87 EGFR (1.00) EGFRERBB2
SCHEMBL6505438 0.86 EGFR (0.62) EGFRERBB2
SCHEMBL1418228 0.86 EGFR (0.72) EGFRERBB2
SCHEMBL1418229 0.86 EGFR (0.72) EGFRERBB2
SCHEMBL1417992 0.85 EGFR (0.80) EGFRERBB2
SCHEMBL1417990 0.85 EGFR (0.80) EGFRERBB2
SCHEMBL1417860 0.85 EGFR (0.82) EGFRERBB2
SCHEMBL1417858 0.85 EGFR (0.82) EGFRERBB2
SCHEMBL7839268 0.85 EGFR (0.58) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298746-A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-03-23 — — EP disclosed
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 — — US disclosed
Send feedback